Medistim ASA
OSE:MEDI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (31.9), the stock would be worth kr277.87 (21% upside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 26.4 | kr230 |
0%
|
| 3-Year Average | 31.9 | kr277.87 |
+21%
|
| 5-Year Average | 36.5 | kr317.91 |
+38%
|
| Industry Average | 30.5 | kr265.91 |
+16%
|
| Country Average | 15.4 | kr134.36 |
-42%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
kr4B
|
/ |
Jan 2026
kr159.2m
|
= |
|
|
kr4B
|
/ |
Dec 2026
kr142.4m
|
= |
|
|
kr4B
|
/ |
Dec 2027
kr158.4m
|
= |
|
|
kr4B
|
/ |
Dec 2028
kr177.2m
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| NO |
|
Medistim ASA
OSE:MEDI
|
4.1B NOK | 26.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.2B USD | 60 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.3B USD | 25.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.3B USD | 38.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.9B USD | 23.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
92B USD | 25.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD | 44.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40B EUR | 18.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.1B USD | 42.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
43.3B USD | 24.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32B USD | 21.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 11.2 |
| Median | 15.4 |
| 70th Percentile | 22.2 |
| Max | 3 316.8 |
Other Multiples
Medistim ASA
Glance View
Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.
